ImmunityBio, Inc. (IBRX) Earnings
|
Expand Research on IBRX
| Next EPS Date | 8/5/26 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +18.9% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +9.5% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/7/26  |
Q126 | N/A | -$0.08 | N/A | N/A | $43.85M | N/A | N/A | N/A | ||
| 2/23/26 |
Q425 | -$0.06 | -$0.11 | +$0.05 | $38.28M | $35.99M | N/A |  | | Details | |
| 11/5/25 |
Q325 | -$0.07 | -$0.11 | +$0.04 | $32.06M | $31.88M | N/A | | | Details | |
| 8/5/25 |
Q225 | -$0.10 | -$0.11 | +$0.01 | $26.43M | $21.49M | N/A | | | Details | |
| 5/12/25 | Q125 | -$0.15 | -$0.13 | -$0.02 | $16.5M | $16.86M | N/A | | | Details | |
| 5/8/25 |
Q125 | N/A | -$0.13 | N/A | N/A | $16.86M | N/A | N/A | N/A | ||
| 3/3/25 |
Q424 | -$0.09 | -$0.17 | +$0.08 | $7.2M | $6.16M | N/A | | | Details | |
| 11/12/24 |
Q324 | -$0.14 | -$0.18 | +$0.04 | $6.1M | $2.93M | N/A | | | Details |
